Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal
Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal
5.3Significance
1 source7.0Source trust
Top stories · Organization
Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal